Cargando…
Clinical validation and diagnostic accuracy of (99m)Tc-EDDA/HYNIC-TOC compared to (111)In-DTPA-octreotide in patients with neuroendocrine tumours: the LACOG 0214 study
(99m)Tc-EDDA/HYNIC-TOC is an easily available and cheaper radionuclide that could be used for somatostatin-receptor-based imaging of neuroendocrine tumours (NETs). We aimed to evaluate the diagnostic performance of (99m)Tc-EDDA/HYNIC-TOC compared to(111)In-DTPA-octreotide in patients (pts) with NETs...
Autores principales: | Moriguchi-Jeckel, Cristina M, Madke, Rafael R, Radaelli, Graciane, Viana, Alice, Nabinger, Patrícia, Fernandes, Bruna, Gössling, Gustavo, Berdichevski, Eduardo H, Vilas, Eduardo, Giacomazzi, Juliana, Rocha, Matheus Soares, Borges, João Alfredo, Hoffmann, Elias, Greggio, Samuel, Venturin, Gianina T, Barrios, Carlos H, Zaffaroni, Facundo, Werutsky, Gustavo, da Costa, Jaderson C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393301/ https://www.ncbi.nlm.nih.gov/pubmed/37533941 http://dx.doi.org/10.3332/ecancer.2023.1582 |
Ejemplares similares
-
The New Radiolabeled Peptide (99m)TcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs?
por: Gherghe, Mirela, et al.
Publicado: (2022) -
(99m)Tc-EDDA/HYNIC-TOC is a New Opportunity in Neuroendocrine Tumors of the Lung (and in other Malignant and Benign Pulmonary Diseases)
por: Briganti, Vittorio, et al.
Publicado: (2020) -
(99m)Tc-Hynic-TOC imaging in the diagnostic of neuroendocrine tumors
por: Liepe, Knut, et al.
Publicado: (2018) -
(99m)Tc-HYNIC-(tricine/EDDA)-FROP peptide for MCF-7 breast tumor targeting and imaging
por: Ahmadpour, Sajjad, et al.
Publicado: (2018) -
The Diagnostic Efficiency of 99mTc-EDDA/HYNIC-Octreotate SPECT-CT in Comparison with 111In-Pentetrotide in the Detection of Neuroendocrine Tumours
por: Koçyiğit Deveci, Emel, et al.
Publicado: (2013)